Literature DB >> 21046394

Sequence analysis of East Asian cagA of Helicobacter pylori isolated from asymptomatic healthy Japanese and Thai individuals.

Itaru Hirai1, Aya Yoshinaga, Ai Kimoto, Tadahiro Sasaki, Yoshimasa Yamamoto.   

Abstract

CagA, especially East Asian type, is one of the most important virulence factors of Helicobacter pylori, which is believed to contribute to the gastric cancer development. There is extreme sequence heterogeneity on 3' region of cagA gene, demonstrated by the sequence analysis of cagA of H. pylori strains isolated from gastric disease patients. However, whether such heterogeneity of the cagA gene sequence is related to the pathogenicity of H. pylori in the gastric cancer development is not certain. Therefore, in this study, the 3' region of cagA sequences isolated from asymptomatic healthy individuals in Japan and Thailand, which show high and low gastric cancer prevalence, respectively, were analyzed and compared with those from patients with gastric cancer. The CagA sequences analysis in 21 and 12 H. pylori DNA samples obtained from Japanese and Thai individuals, respectively, by the molecular phylogenetic method showed that the sequences were more conserved in the Thai individuals (concordance rates among Thai sequences, 93.9-100%) than in the Japanese individuals (concordance rates among Japanese sequences, 82.8-100%) as shown by unrooted neighbor-joining (N-J) consensus trees constructed with the sequence between Asn869 and Ala967 in CagA. CagA sequences in gastric cancer patients were obtained from published data; analysis of these sequences revealed that CagA sequences from almost all Thai individuals were concentrated in one branch. In contrast, CagA sequences from Japanese individuals were uniformly distributed throughout the N-J consensus tree. These results suggest that the difference in the CagA sequences between asymptomatic healthy Japanese and Thai individuals may be linked to the incidence of gastric cancer in Japan and Thailand.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21046394     DOI: 10.1007/s00284-010-9797-9

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  27 in total

1.  High prevalence of CTX-M beta-lactamase-producing Enterobacteriaceae in stool specimens obtained from healthy individuals in Thailand.

Authors:  Tadahiro Sasaki; Itaru Hirai; Marie Niki; Tatsuya Nakamura; Chalit Komalamisra; Wanna Maipanich; Teera Kusolsuk; Surapol Sa-Nguankiat; Somchit Pubampen; Yoshimasa Yamamoto
Journal:  J Antimicrob Chemother       Date:  2010-01-27       Impact factor: 5.790

2.  Grb2 is a key mediator of helicobacter pylori CagA protein activities.

Authors:  Hitomi Mimuro; Toshihiko Suzuki; Jiro Tanaka; Momoyo Asahi; Rainer Haas; Chihiro Sasakawa
Journal:  Mol Cell       Date:  2002-10       Impact factor: 17.970

Review 3.  H. pylori and gastric cancer: the Asian enigma.

Authors:  Hiroto Miwa; Mae F Go; Nobuhiro Sato
Journal:  Am J Gastroenterol       Date:  2002-05       Impact factor: 10.864

4.  East Asian-type Helicobacter pylori cytotoxin-associated gene A protein has a more significant effect on growth of rat gastric mucosal cells than the Western type.

Authors:  Hai Ying Fu; Kayoko Asahi; Yujiro Hayashi; Hiroshi Eguchi; Hiroaki Murata; Masahiko Tsujii; Shingo Tsuji; Takeshi Azuma; Sunao Kawano
Journal:  J Gastroenterol Hepatol       Date:  2007-03       Impact factor: 4.029

Review 5.  Helicobacter pylori and gastric carcinogenesis.

Authors:  Masanori Hatakeyama
Journal:  J Gastroenterol       Date:  2009-03-07       Impact factor: 7.527

Review 6.  Causal role of Helicobacter pylori infection in gastric cancer: an Asian enigma.

Authors:  Kartar Singh; Uday C Ghoshal
Journal:  World J Gastroenterol       Date:  2006-03-07       Impact factor: 5.742

7.  Development of gastric cancer associated with Helicobacter pylori infection.

Authors:  Toshiro Sugiyama
Journal:  Cancer Chemother Pharmacol       Date:  2004-09       Impact factor: 3.333

8.  Helicobacter pylori regulates cellular migration and apoptosis by activation of phosphatidylinositol 3-kinase signaling.

Authors:  Toni A Nagy; Mark R Frey; Fang Yan; Dawn A Israel; D Brent Polk; Richard M Peek
Journal:  J Infect Dis       Date:  2009-03-01       Impact factor: 5.226

9.  Infection of less virulent Helicobacter pylori strains in asymptomatic healthy individuals in Thailand as a potential contributing factor to the Asian enigma.

Authors:  Itaru Hirai; Tadahiro Sasaki; Ai Kimoto; Yoshimasa Yamamoto; Takeshi Azuma; Varocha Mahachai; Piyathida Hansomburana; Comsun Lertkupinit; Somchai Luangjaru; Phadet Noophan; Rattikorn Chanatrirattanapan; Vanich Piyanirandr; Theeranan Sappajit; Karun Suthivarakom; Leelaowadee Sangsuk; Piyada Wangroongsarb
Journal:  Microbes Infect       Date:  2009-12-28       Impact factor: 2.700

10.  Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response.

Authors:  Yuri Churin; Laila Al-Ghoul; Oliver Kepp; Thomas F Meyer; Walter Birchmeier; Michael Naumann
Journal:  J Cell Biol       Date:  2003-04-28       Impact factor: 10.539

View more
  3 in total

1.  Multiplex Accelerated PCR System for One-Step Helicobacter pylori cagA + Genotypes Detection: A Guide for Clinical Testing.

Authors:  Yanling Wang; Yang Li; Zhixian Luan; Yan Zhao; Peng Zhang; Cuiping Ma; Chao Shi
Journal:  Curr Microbiol       Date:  2022-06-29       Impact factor: 2.188

2.  Elevated prevalence of Helicobacter species and virulence factors in opisthorchiasis and associated hepatobiliary disease.

Authors:  Raksawan Deenonpoe; Eimorn Mairiang; Pisaln Mairiang; Chawalit Pairojkul; Yaovalux Chamgramol; Gabriel Rinaldi; Alex Loukas; Paul J Brindley; Banchob Sripa
Journal:  Sci Rep       Date:  2017-02-15       Impact factor: 4.379

3.  Phylogenetic analysis of Helicobacter pylori cagA gene of Turkish isolates and the association with gastric pathology.

Authors:  Barik A Salih; Bora Kazim Bolek; Mehmet Taha Yildiz; Soykan Arikan
Journal:  Gut Pathog       Date:  2013-11-18       Impact factor: 4.181

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.